The device giant also reported net sales totaling $739.5 million for the fourth quarter of fiscal year 2012, a 3 percent increase compared to the same quarter last year, as well as an operating loss of $378 million during the fourth quarter of fiscal year 2012, compared to an operating loss of $847.3 million for the same period last year.
More Articles on Biomet:
41 Orthopedic & Spine Devices Receive FDA 510(k) Clearance in June
20 Spine Devices Receive FDA 510(k) Clearance in June
Biomet Closes DePuy Trauma Acquisition
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
